Discussing the technological supremacy of the chemical industry, including pharmaceuticals, and how it will adopt a leading position to solve some of the largest global challenges humans have even seen, this book details how the industry will address climate change, aging populations, resource scarcity, globality, networks speed, pandemics, and massive growth and demand. Following a detailed introduction to some of the megatrends shaping our world over the forthcoming decades, the book goes on to provide several scenarios of how the world could look by 2050, including 'business as usual' and a 'sustainable' one. Chapter 3 gives a comprehensive overview of the current status, while providing a short historical review of the chemical industry, its origins, achievements and fundamentals. The following chapter reviews the potential impact of each of the selected megatrends on the industry, while Chapter 5 proposes how it could look by 2050. Several features of the chemical industry are presented and discussed, including the industrial relevance from an economical, technological and profitability point of view. The largest chemicals markets in absolute and per capita bases and the areas and countries with largest growth potential for chemicals, pharmaceuticals and feedstock. This chapter also reviews the impact of climate change on the chemical industry from a feedstocks and products point of view and, more specifically, the potential costs in reducing CO2 emissions. A final, concluding chapter summarizes the forthcoming megatrends and potential challenges, opportunities and the outlook for the industry as a whole.

Fred Aftalion's international perspective of the history of chemistry integrates the story of chemical science with that of chemical industry. This new edition includes events from 1990 to 2000, when major companies began selling off their divisions, seeking to specialize in a particular business. Aftalion explores the pitfalls these companies encountered as well as the successes of "contrarians"--those companies that remained broad and diversified. He uses BASF, Dow, and Bayer as examples of true contrarians.

Separation processes—or processes that use physical, chemical, or electrical forces to isolate or concentrate selected constituents of a mixture—are essential to the chemical, petroleum refining, and materials processing industries. In this volume, an expert panel reviews the separation process needs of seven industries and identifies technologies that hold promise for meeting these needs, as well as key technologies that could enable separations. In addition, the book recommends criteria for the selection of separations research projects for the Department of Energy's Office of Industrial Technology.

WINNER OF THE PULITZER PRIZE • Winner of The New York Public Library’s Helen Bernstein Book Award • “A new classic of science reporting.”—The New York Times The riveting true story of a small town ravaged by industrial pollution, Toms River melds hard-hitting investigative reporting, a fascinating scientific detective story, and an unforgettable cast of characters into a sweeping narrative in the tradition of A Civil Action, The Emperor of All Maladies, and The Immortal Life of Henrietta Lacks. One of New Jersey’s seemingly innumerable quiet seaside towns, Toms River became the unlikely setting for a decades-long drama that culminated in 2001 with one of the largest legal settlements in the annals of toxic dumping. A town that would rather have been known for its Little League World Series champions ended up making history for an entirely different reason: a notorious cluster of childhood cancers scientifically linked to local air and water pollution. For years, large chemical companies had been using Toms River as their private dumping ground, burying tens of thousands of leaky drums in open pits and discharging billions of gallons of acid-laced wastewater into the town’s namesake river. In an astonishing feat of investigative reporting, prize-winning journalist Dan Fagin recounts the sixty-year saga of rampant pollution and inadequate oversight that made Toms River a cautionary example for fast-growing industrial towns from South Jersey to South China. He tells the stories of the pioneering scientists and physicians who first identified pollutants as a cause of cancer, and brings to life the everyday heroes in Toms River who struggled for justice: a young boy whose cherubic smile belied the fast-growing tumors that had decimated his body from birth; a nurse who fought to bring the alarming incidence of childhood cancers to the attention of authorities who didn’t want to listen; and a mother whose love for her stricken child transformed her into a tenacious advocate for change. A gripping human drama rooted in a centuries-old scientific quest, Toms River is a tale of dumpers at midnight and deceptions in broad daylight, of corporate avarice and government neglect, and of a few brave individuals who refused to keep silent until the truth was exposed. NAMED ONE OF THE BEST BOOKS OF THE YEAR BY NPR AND KIRKUS REVIEWS “A thrilling journey full of twists and turns, Toms River is essential reading for our times. Dan Fagin handles topics of great complexity with the dexterity of a scholar, the honesty of a journalist, and the dramatic skill of a novelist.”—Siddhartha Mukherjee, M.D., author of the Pulitzer Prize–winning The Emperor of All Maladies “A complex tale of powerful industry, local politics, water rights, epidemiology, public health and cancer in a gripping, page-turning environmental thriller.”—NPR “Unstoppable reading.”—The Philadelphia Inquirer “Meticulously researched and compellingly recounted . . . It’s every bit as important—and as well-written—as A Civil Action and The Immortal Life of Henrietta Lacks.”—The Star-Ledger “Fascinating . . . a gripping environmental thriller.”—Kirkus Reviews (starred review) “An honest, thoroughly researched, intelligently written book.”—Slate “[A] hard-hitting account . . . a triumph.”—Nature “Absorbing and thoughtful.”—USA Today

This book is a comprehensive reference on one of the most exciting and challenging segments of the modern chemical industry. It comprises descriptions of the leading fine chemical companies, the products, markets and technologies on a global basis. It serves also as a guide for developing and succeeding in the $60 billion fine chemicals business, which is usually lumped into the chemical or pharmaceutical industry.